Fat stem cells injected into fingers aim to heal scleroderma ulcers
NCT ID NCT04356755
First seen Jan 06, 2026 · Last updated Jun 22, 2026 · Updated 26 times
Summary
This phase 2 trial tests whether injecting stem cells from fat tissue directly into finger ulcers can help them heal in people with scleroderma. The study will compare the stem cell treatment to a placebo in 32 adults who have at least one painful, non-healing finger sore. The goal is to see if the stem cells can close the wound and prevent it from coming back without serious side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
CHU de Toulouse - Hôpital PURPAN-TSA
RECRUITINGToulouse, 31059, France
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Grenoble Hospital
NOT_YET_RECRUITINGGrenoble, France
Contact
-
Lille Hopsital
NOT_YET_RECRUITINGLille, France
Contact
-
Marseille Hospital
NOT_YET_RECRUITINGMarseille, France
Contact
-
Montpellier Hospital
NOT_YET_RECRUITINGMontpellier, France
Contact
-
Nantes Hospital
NOT_YET_RECRUITINGNantes, France
Contact
-
Poitiers Hospital
NOT_YET_RECRUITINGPoitiers, France
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cultured adipose-derived stem cells (AdMSC)
What this could lead to
If it works, this could offer a new way to heal stubborn finger ulcers in scleroderma, improving hand function and quality of life.
What could go wrong
This is a small early-phase trial with only 32 participants. The treatment may not heal ulcers better than placebo, and there are risks like infection or worsening of the ulcer.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.